|
Market Closed -
Nasdaq
23:00:00 17/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 138.92 USD | +0.40% |
|
+4.40% | +13.18% |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
| 08-11 | Nucleai And Gilead Sciences Advance AI-Powered Tissue Intelligence Through Large-Scale Oncology ADC Collaboration | CI |
| Market Cap | 172B 149B 140B 127B 239B 16,470B 242B 1,635B 641B 8,251B 647B 633B 27,448B | P/E 2026 * |
-42.4x | P/E 2027 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 189B 163B 153B 139B 262B 18,071B 266B 1,794B 703B 9,053B 710B 694B 30,116B | EV / Sales 2026 * |
6.16x | EV / Sales 2027 * | 5.55x |
| Free-Float |
99.88% | Yield 2026 * |
2.37% | Yield 2027 * | 2.44% |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +0.40% | ||
| 1 week | +4.40% | ||
| Current month | +6.69% | ||
| 1 month | +3.46% | ||
| 3 months | +7.21% | ||
| 6 months | -10.53% | ||
| Current year | +13.18% |
| 1 week | 133.3 |  | 139.49 |
| 1 month | 127.61 | | 139.49 |
| Current year | 116.88 | | 157.29 |
| 1 year | 108.46 | | 157.29 |
| 3 years | 62.07 | | 157.29 |
| 5 years | 57.16 | | 157.29 |
| 10 years | 56.56 | | 157.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 01/03/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 01/11/2019 |
Keeley Wettan
CMP | Compliance Officer | - | 18/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 19/08/2016 |
| Director/Board Member | 73 | 01/01/2018 | |
Harish Manwani
BRD | Director/Board Member | 72 | 09/05/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/10/26 A | Fiscal year | EVP Gen Counsel, Legal & Comp | 14,912 | 0.0012% | ||
| 8/3/26 A | Sell | Chief Executive Officer | -15,000 | 0.0012% | ||
| 7/15/26 A | Sell | Executive/Senior Manager | -3,000 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.40% | +4.40% | +17.36% | +81.59% | 172B | |
| +0.25% | -3.96% | +68.73% | +120.06% | 1,055B | |
| +0.78% | +0.21% | +48.53% | +50.78% | 632B | |
| +0.35% | +0.95% | +21.11% | +66.86% | 442B | |
| +0.28% | -4.56% | +39.10% | +38.05% | 351B | |
| +0.78% | -2.68% | +24.03% | +37.32% | 290B | |
| +0.87% | -3.59% | -0.28% | +7.12% | 243B | |
| +1.00% | +0.52% | +41.46% | +58.95% | 227B | |
| -0.78% | -4.49% | -10.28% | -54.13% | 200B | |
| +0.30% | -0.67% | +6.88% | -26.40% | 153B | |
| Average | +0.42% | -1.29% | +25.67% | +38.02% | 376.57B | |
| Weighted average by Cap. | +0.43% | -1.79% | +38.38% | +60.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.71B 26.51B 24.87B 22.65B 42.59B 2,936B 43.18B 292B 114B 1,471B 115B 113B 4,893B | 32.7B 28.23B 26.48B 24.12B 45.35B 3,126B 45.98B 310B 122B 1,566B 123B 120B 5,210B |
| Net income | -4.27B -3.69B -3.46B -3.15B -5.93B -409B -6.01B -40.59B -15.9B -205B -16.05B -15.7B -681B | 10.28B 8.87B 8.32B 7.58B 14.25B 982B 14.45B 97.55B 38.23B 492B 38.58B 37.74B 1,637B |
| Net Debt | 16.75B 14.46B 13.56B 12.35B 23.23B 1,601B 23.55B 159B 62.3B 802B 62.87B 61.51B 2,668B | 9.12B 7.88B 7.39B 6.73B 12.66B 872B 12.83B 86.63B 33.95B 437B 34.26B 33.52B 1,454B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/08/26 | $138.92 | +0.40% | 3,940,375 |
| 14/08/26 | $138.36 | +0.16% | 3,407,825 |
| 13/08/26 | $138.14 | +1.67% | 4,897,034 |
| 12/08/26 | $135.87 | +0.07% | 5,683,968 |
| 11/08/26 | $135.77 | +2.04% | 5,493,691 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
